NanoEcho
0.07 SEK
-5.28 %
Less than 1K followers
NANECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-5.28 %
-6.73 %
+21.69 %
-20.97 %
-7.31 %
-59.62 %
-
-
-52.86 %
NanoEcho operates in the healthcare sector, with a primary focus on rectal cancer diagnostics. The company is currently in the clinical stage, developing a new diagnostic method to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide an accurate diagnosis and personalized treatment. NanoEcho was founded in 2013 and is headquartered in Lund.
Read moreMarket cap
21.53M SEK
Turnover
42.17K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2
2026
Annual report '25
30.4
2026
Interim report Q1'26
28.5
2026
General meeting '26